GlassScriptPhysician profile
Bogdana Schmidt
NPI 1386987865
$35,995.42
in general payments reported to CMS, 2019-2025
13 companies · $18K in 2025
The $18K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $312 · 2023: $420 · 2024: $17K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,300 · Education: $4,000 · Honoraria: $3,750 · Travel and Lodging: $3,485 · Food and Beverage: $2,432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,597.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,300.00 |
| Education | $4,000.00 |
| Honoraria | $3,750.00 |
| Travel and Lodging | $3,484.62 |
| Food and Beverage | $2,431.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $18,644.90 | 2024-2025 | Adstiladrin |
| Intuitive Surgical, INC. | $7,199.49 | 2024-2025 | |
| Urogen Pharma, INC. | $4,086.50 | 2022-2024 | |
| Janssen Global Services, LLC | $3,084.39 | 2025 | |
| Janssen Scientific Affairs, LLC | $1,031.37 | 2025 | |
| Janssen Biotech, INC. | $964.71 | 2025 | Erleada |
| Janssen Research & Development, LLC | $280.00 | 2022-2023 | |
| Coloplast Corp | $268.76 | 2023-2025 | Titan |
| Boston Scientific Corporation | $233.58 | 2021-2024 | Lithovue, Tria Firm |
| Fennec Pharmaceuticals, INC. | $136.66 | 2023 | Pedmark |
| Teleflex LLC | $35.61 | 2023 | Urolift |
| Myriad Genetic Laboratories, INC. | $29.45 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bogdana Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.